Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.
Market Analysis and Insights: Global Biologics Safety Testing Market
In 2019, the global Biologics Safety Testing market size was US$ 2467.4 million and it is expected to reach US$ 3976.4 million by the end of 2026, with a CAGR of 7.0% during 2021-2026.
Global Biologics Safety Testing Scope and Market Size
Biologics Safety Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biologics Safety Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Biologics Safety Testing market is segmented into Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization Tests, Bioburden Tests, Cell Line Authentication, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, Others, etc.
Segment by Application, the Biologics Safety Testing market is segmented into Vaccine Development, Blood Products Testing, Cellular & Gene Therapy, Tissue and Tissue-Related Products Testing, Stem Cell Research, etc.
Regional and Country-level Analysis
The Biologics Safety Testing market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biologics Safety Testing market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Biologics Safety Testing Market Share Analysis
Biologics Safety Testing market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Biologics Safety Testing business, the date to enter into the Biologics Safety Testing market, Biologics Safety Testing product introduction, recent developments, etc.
The major vendors include Lonza Group, Charles River, Merck, SGS, WuXi AppTec, Thermo Fisher Scientific, Sartorius, Cytovance Biologics, Pace Analytical Services, Toxikon, etc.

This report focuses on the global Biologics Safety Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biologics Safety Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Lonza Group
Charles River
Merck
SGS
WuXi AppTec
Thermo Fisher Scientific
Sartorius
Cytovance Biologics
Pace Analytical Services
Toxikon

Market segment by Type, the product can be split into

Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Cell Line Authentication
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Others

Market segment by Application, split into

Vaccine Development
Blood Products Testing
Cellular & Gene Therapy
Tissue and Tissue-Related Products Testing
Stem Cell Research

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Biologics Safety Testing status, future forecast, growth opportunity, key market and key players.
To present the Biologics Safety Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Biologics Safety Testing are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.